25 XP   0   0   10

Oncosil Medical Ltd
Buy, Hold or Sell?

Let's analyse Oncosil together

PenkeI guess you are interested in Oncosil Medical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oncosil Medical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Oncosil Medical Ltd

I send you an email if I find something interesting about Oncosil Medical Ltd.

Quick analysis of Oncosil (30 sec.)










What can you expect buying and holding a share of Oncosil? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-35.0%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.005 - A$0.0080405405405405
How sure are you?
50%

1. Valuation of Oncosil (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$-0.08 - A$-0.04

Total Value Per Share

A$-0.07 - A$-0.03

2. Growth of Oncosil (5 min.)




Is Oncosil growing?

Current yearPrevious yearGrowGrow %
How rich?$6.3m$7.1m-$821.2k-13.0%

How much money is Oncosil making?

Current yearPrevious yearGrowGrow %
Making money-$7.2m-$6.8m-$394.6k-5.4%
Net Profit Margin-3,085.0%-4,627.8%--

How much money comes from the company's main activities?

3. Financial Health of Oncosil (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#251 / 340

Most Revenue
#295 / 340

Most Profit
#243 / 340

Most Efficient
#318 / 340

What can you expect buying and holding a share of Oncosil? (5 min.)

Welcome investor! Oncosil's management wants to use your money to grow the business. In return you get a share of Oncosil.

What can you expect buying and holding a share of Oncosil?

First you should know what it really means to hold a share of Oncosil. And how you can make/lose money.

Speculation

The Price per Share of Oncosil is A$0.007. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oncosil.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oncosil, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oncosil.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-49.6%0.00-49.6%0.00-46.9%0.00-39.7%0.00-33.0%
Usd Book Value Change Per Share0.00-5.6%0.00-5.6%0.00-2.3%0.00-7.2%0.001.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.0014.6%0.007.3%
Usd Total Gains Per Share0.00-5.6%0.00-5.6%0.00-2.3%0.007.4%0.009.0%
Usd Price Per Share0.01-0.01-0.03-0.04-0.06-
Price to Earnings Ratio-2.34--2.34--8.26--19.05--35.97-
Price-to-Total Gains Ratio-20.71--20.71--166.12--40.97--15.41-
Price to Book Ratio2.69-2.69-7.94-8.65-16.35-
Price-to-Total Gains Ratio-20.71--20.71--166.12--40.97--15.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0044828
Number of shares223074
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (223074 shares)-87.62114.97
Gains per Year (223074 shares)-350.49459.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-350-360912-452450
20-701-7101824-905910
30-1051-10602737-13571370
40-1402-14103649-18091830
50-1752-17604561-22622290
60-2103-21105473-27142750
70-2453-24606385-31663210
80-2804-28107297-36183670
90-3154-31608210-40714130
100-3505-35109122-45234590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.019.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%9.010.00.047.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.09.010.0%1.00.018.05.3%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%9.010.00.047.4%

Fundamentals of Oncosil

About Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Fundamental data was last updated by Penke on 2024-04-02 21:22:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Oncosil Medical Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oncosil earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • A Net Profit Margin of -3,085.0% means that $-30.85 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncosil Medical Ltd:

  • The MRQ is -3,085.0%. The company is making a huge loss. -2
  • The TTM is -3,085.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-3,085.0%TTM-3,085.0%0.0%
TTM-3,085.0%YOY-4,627.8%+1,542.8%
TTM-3,085.0%5Y-2,577.2%-507.8%
5Y-2,577.2%10Y-1,480.5%-1,096.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,085.0%-11.2%-3,073.8%
TTM-3,085.0%-19.6%-3,065.4%
YOY-4,627.8%-14.4%-4,613.4%
5Y-2,577.2%-21.3%-2,555.9%
10Y-1,480.5%-24.8%-1,455.7%
1.1.2. Return on Assets

Shows how efficient Oncosil is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • -98.9% Return on Assets means that Oncosil generated $-0.99 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncosil Medical Ltd:

  • The MRQ is -98.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -98.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-98.9%TTM-98.9%0.0%
TTM-98.9%YOY-82.1%-16.8%
TTM-98.9%5Y-62.5%-36.4%
5Y-62.5%10Y-51.8%-10.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-98.9%-4.0%-94.9%
TTM-98.9%-4.5%-94.4%
YOY-82.1%-4.8%-77.3%
5Y-62.5%-4.0%-58.5%
10Y-51.8%-5.2%-46.6%
1.1.3. Return on Equity

Shows how efficient Oncosil is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • -114.8% Return on Equity means Oncosil generated $-1.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncosil Medical Ltd:

  • The MRQ is -114.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -114.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-114.8%TTM-114.8%0.0%
TTM-114.8%YOY-96.1%-18.7%
TTM-114.8%5Y-72.7%-42.1%
5Y-72.7%10Y-58.8%-13.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-114.8%-3.9%-110.9%
TTM-114.8%-5.6%-109.2%
YOY-96.1%-5.9%-90.2%
5Y-72.7%-6.1%-66.6%
10Y-58.8%-7.1%-51.7%

1.2. Operating Efficiency of Oncosil Medical Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oncosil is operating .

  • Measures how much profit Oncosil makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • An Operating Margin of -3,414.3% means the company generated $-34.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncosil Medical Ltd:

  • The MRQ is -3,414.3%. The company is operating very inefficient. -2
  • The TTM is -3,414.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-3,414.3%TTM-3,414.3%0.0%
TTM-3,414.3%YOY-4,922.3%+1,508.0%
TTM-3,414.3%5Y-2,875.9%-538.4%
5Y-2,875.9%10Y-1,685.9%-1,190.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,414.3%-22.8%-3,391.5%
TTM-3,414.3%-17.1%-3,397.2%
YOY-4,922.3%-13.4%-4,908.9%
5Y-2,875.9%-19.2%-2,856.7%
10Y-1,685.9%-24.0%-1,661.9%
1.2.2. Operating Ratio

Measures how efficient Oncosil is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 35.14 means that the operating costs are $35.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 35.143. The company is inefficient in keeping operating costs low. -1
  • The TTM is 35.143. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ35.143TTM35.1430.000
TTM35.143YOY50.223-15.080
TTM35.1435Y29.359+5.784
5Y29.35910Y17.159+12.200
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ35.1431.428+33.715
TTM35.1431.426+33.717
YOY50.2231.503+48.720
5Y29.3591.440+27.919
10Y17.1591.371+15.788

1.3. Liquidity of Oncosil Medical Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oncosil is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 7.16 means the company has $7.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 7.160. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.160. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.160TTM7.1600.000
TTM7.160YOY7.209-0.049
TTM7.1605Y8.704-1.545
5Y8.70410Y17.268-8.564
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1602.787+4.373
TTM7.1602.763+4.397
YOY7.2093.488+3.721
5Y8.7043.617+5.087
10Y17.2683.514+13.754
1.3.2. Quick Ratio

Measures if Oncosil is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • A Quick Ratio of 6.88 means the company can pay off $6.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 6.880. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.880. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.880TTM6.8800.000
TTM6.880YOY6.945-0.064
TTM6.8805Y8.589-1.709
5Y8.58910Y19.652-11.063
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8801.539+5.341
TTM6.8801.660+5.220
YOY6.9452.139+4.806
5Y8.5892.300+6.289
10Y19.6522.255+17.397

1.4. Solvency of Oncosil Medical Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oncosil assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oncosil to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.14 means that Oncosil assets are financed with 13.9% credit (debt) and the remaining percentage (100% - 13.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 0.139. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.139. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.139TTM0.1390.000
TTM0.139YOY0.146-0.007
TTM0.1395Y0.127+0.012
5Y0.12710Y0.100+0.027
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1390.389-0.250
TTM0.1390.386-0.247
YOY0.1460.338-0.192
5Y0.1270.442-0.315
10Y0.1000.460-0.360
1.4.2. Debt to Equity Ratio

Measures if Oncosil is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oncosil to the Medical Devices industry mean.
  • A Debt to Equity ratio of 16.1% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 0.161. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.161. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.161TTM0.1610.000
TTM0.161YOY0.171-0.010
TTM0.1615Y0.147+0.015
5Y0.14710Y0.114+0.033
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1610.559-0.398
TTM0.1610.560-0.399
YOY0.1710.478-0.307
5Y0.1470.624-0.477
10Y0.1140.674-0.560

2. Market Valuation of Oncosil Medical Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Oncosil generates.

  • Above 15 is considered overpriced but always compare Oncosil to the Medical Devices industry mean.
  • A PE ratio of -2.34 means the investor is paying $-2.34 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncosil Medical Ltd:

  • The EOD is -1.290. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.341. Based on the earnings, the company is expensive. -2
  • The TTM is -2.341. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.290MRQ-2.341+1.051
MRQ-2.341TTM-2.3410.000
TTM-2.341YOY-8.264+5.923
TTM-2.3415Y-19.048+16.708
5Y-19.04810Y-35.974+16.925
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.290-1.037-0.253
MRQ-2.341-1.578-0.763
TTM-2.341-2.041-0.300
YOY-8.264-2.971-5.293
5Y-19.048-2.058-16.990
10Y-35.974-1.463-34.511
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oncosil Medical Ltd:

  • The EOD is -1.287. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.335. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.335. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.287MRQ-2.335+1.048
MRQ-2.335TTM-2.3350.000
TTM-2.335YOY-8.763+6.428
TTM-2.3355Y-1,595.392+1,593.057
5Y-1,595.39210Y-919.824-675.568
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.287-1.007-0.280
MRQ-2.335-1.544-0.791
TTM-2.335-3.018+0.683
YOY-8.763-6.339-2.424
5Y-1,595.392-4.928-1,590.464
10Y-919.824-4.950-914.874
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oncosil is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.69 means the investor is paying $2.69 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncosil Medical Ltd:

  • The EOD is 1.481. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.687. Based on the equity, the company is underpriced. +1
  • The TTM is 2.687. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.481MRQ2.687-1.206
MRQ2.687TTM2.6870.000
TTM2.687YOY7.941-5.254
TTM2.6875Y8.647-5.959
5Y8.64710Y16.345-7.699
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.4811.987-0.506
MRQ2.6872.379+0.308
TTM2.6872.444+0.243
YOY7.9413.215+4.726
5Y8.6473.833+4.814
10Y16.3454.163+12.182
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Oncosil Medical Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Oncosil Medical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%0.000-58%-0.001+29%0.000-435%
Book Value Per Share--0.0050.0050%0.005-11%0.006-24%0.006-23%
Current Ratio--7.1607.1600%7.209-1%8.704-18%17.268-59%
Debt To Asset Ratio--0.1390.1390%0.146-5%0.127+10%0.100+39%
Debt To Equity Ratio--0.1610.1610%0.171-6%0.147+10%0.114+41%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Eps---0.005-0.0050%-0.005-5%-0.004-20%-0.004-34%
Free Cash Flow Per Share---0.005-0.0050%-0.005-11%-0.003-39%-0.003-47%
Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-49%0.002-148%0.002-143%
Gross Profit Margin--1.0111.0110%1.035-2%1.035-2%1.017-1%
Intrinsic Value_10Y_max---0.037--------
Intrinsic Value_10Y_min---0.076--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.006--------
Intrinsic Value_3Y_max---0.010--------
Intrinsic Value_3Y_min---0.019--------
Intrinsic Value_5Y_max---0.017--------
Intrinsic Value_5Y_min---0.034--------
Market Cap14634830.336-81%26551763.61026551763.6100%88645258.035-70%120800070.973-78%208107287.378-87%
Net Profit Margin---30.850-30.8500%-46.278+50%-25.772-16%-14.805-52%
Operating Margin---34.143-34.1430%-49.223+44%-28.759-16%-16.859-51%
Operating Ratio--35.14335.1430%50.223-30%29.359+20%17.159+105%
Pb Ratio1.481-81%2.6872.6870%7.941-66%8.647-69%16.345-84%
Pe Ratio-1.290+45%-2.341-2.3410%-8.264+253%-19.048+714%-35.974+1437%
Price Per Share0.007-81%0.0130.0130%0.042-70%0.058-78%0.100-87%
Price To Free Cash Flow Ratio-1.287+45%-2.335-2.3350%-8.763+275%-1595.392+68239%-919.824+39301%
Price To Total Gains Ratio-11.413+45%-20.706-20.7060%-166.123+702%-40.966+98%-15.413-26%
Quick Ratio--6.8806.8800%6.945-1%8.589-20%19.652-65%
Return On Assets---0.989-0.9890%-0.821-17%-0.625-37%-0.518-48%
Return On Equity---1.148-1.1480%-0.961-16%-0.727-37%-0.588-49%
Total Gains Per Share---0.001-0.0010%0.000-58%0.001-176%0.001-163%
Usd Book Value--6327467.7176327467.7170%7148673.130-11%8365698.896-24%8167530.190-23%
Usd Book Value Change Per Share--0.0000.0000%0.000-58%-0.001+29%0.000-435%
Usd Book Value Per Share--0.0030.0030%0.003-11%0.004-24%0.004-23%
Usd Dividend Per Share----0%-0%0.001-100%0.001-100%
Usd Eps---0.003-0.0030%-0.003-5%-0.003-20%-0.002-34%
Usd Free Cash Flow---7283559.301-7283559.3010%-6478292.804-11%-4463651.015-39%-3884278.446-47%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.003-11%-0.002-39%-0.002-47%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%0.000-49%0.001-148%0.001-143%
Usd Market Cap9372145.347-81%17003749.41617003749.4160%56768423.246-70%77360365.451-78%133271906.837-87%
Usd Price Per Share0.004-81%0.0080.0080%0.027-70%0.037-78%0.064-87%
Usd Profit---7264009.810-7264009.8100%-6869380.601-5%-5308674.697-27%-4410336.755-39%
Usd Revenue--235460.351235460.3510%148437.676+59%948628.619-75%1485829.119-84%
Usd Total Gains Per Share--0.0000.0000%0.000-58%0.001-176%0.001-163%
 EOD+3 -5MRQTTM+0 -0YOY+9 -255Y+5 -3110Y+2 -34

4.2. Fundamental Score

Let's check the fundamental score of Oncosil Medical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.290
Price to Book Ratio (EOD)Between0-11.481
Net Profit Margin (MRQ)Greater than0-30.850
Operating Margin (MRQ)Greater than0-34.143
Quick Ratio (MRQ)Greater than16.880
Current Ratio (MRQ)Greater than17.160
Debt to Asset Ratio (MRQ)Less than10.139
Debt to Equity Ratio (MRQ)Less than10.161
Return on Equity (MRQ)Greater than0.15-1.148
Return on Assets (MRQ)Greater than0.05-0.989
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Oncosil Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.978
Ma 20Greater thanMa 500.006
Ma 50Greater thanMa 1000.007
Ma 100Greater thanMa 2000.008
OpenGreater thanClose0.007
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets11,474
Total Liabilities1,594
Total Stockholder Equity9,880
 As reported
Total Liabilities 1,594
Total Stockholder Equity+ 9,880
Total Assets = 11,474

Assets

Total Assets11,474
Total Current Assets11,235
Long-term Assets239
Total Current Assets
Cash And Cash Equivalents 9,394
Short-term Investments 117
Net Receivables 1,286
Other Current Assets 555
Total Current Assets  (as reported)11,235
Total Current Assets  (calculated)11,352
+/- 117
Long-term Assets
Property Plant Equipment 239
Long-term Assets  (as reported)239
Long-term Assets  (calculated)239
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,569
Long-term Liabilities25
Total Stockholder Equity9,880
Total Current Liabilities
Short-term Debt 146
Accounts payable 960
Other Current Liabilities 463
Total Current Liabilities  (as reported)1,569
Total Current Liabilities  (calculated)1,569
+/-0
Long-term Liabilities
Long term Debt Total 25
Long-term Liabilities  (as reported)25
Long-term Liabilities  (calculated)25
+/- 0
Total Stockholder Equity
Common Stock86,507
Retained Earnings -84,368
Accumulated Other Comprehensive Income 7,741
Other Stockholders Equity 0
Total Stockholder Equity (as reported)9,880
Total Stockholder Equity (calculated)9,880
+/-0
Other
Capital Stock86,507
Cash and Short Term Investments 9,394
Common Stock Shares Outstanding 1,196,040
Current Deferred Revenue-146
Liabilities and Stockholders Equity 11,474
Net Debt -9,223
Net Invested Capital 9,880
Net Tangible Assets 9,880
Net Working Capital 9,666
Property Plant and Equipment Gross 584
Short Long Term Debt Total 171



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-30
> Total Assets 
947
8,185
7,002
6,167
5,228
2,959
3,030
2,524
6,244
12,281
7,407
15,897
11,805
19,882
11,668
24,060
14,150
13,069
11,474
11,47413,06914,15024,06011,66819,88211,80515,8977,40712,2816,2442,5243,0302,9595,2286,1677,0028,185947
   > Total Current Assets 
918
3,447
2,538
2,296
1,988
1,919
3,030
2,521
3,592
9,617
7,352
15,805
11,689
19,796
11,606
23,921
13,620
12,745
11,235
11,23512,74513,62023,92111,60619,79611,68915,8057,3529,6173,5922,5213,0301,9191,9882,2962,5383,447918
       Cash And Cash Equivalents 
887
2,821
1,901
1,746
1,395
1,552
2,727
2,412
3,511
2,739
2,523
9,780
8,001
15,205
7,689
20,998
12,240
11,280
9,394
9,39411,28012,24020,9987,68915,2058,0019,7802,5232,7393,5112,4122,7271,5521,3951,7461,9012,821887
       Short-term Investments 
0
0
0
0
0
0
141
80
57
4,350
3,598
3,259
0
0
69
69
91
89
117
11789916969003,2593,5984,3505780141000000
       Net Receivables 
0
611
608
534
499
332
134
5
14
137
75
2,628
3,529
4,483
3,819
2,806
1,181
908
1,286
1,2869081,1812,8063,8194,4833,5292,628751371451343324995346086110
       Other Current Assets 
31
14
29
15
95
35
27
25
10
2,391
1,157
138
159
108
69
118
198
557
555
555557198118691081591381,1572,391102527359515291431
   > Long-term Assets 
28
4,738
4,464
3,871
3,240
1,040
0
2
2,651
2,664
55
92
115
86
62
138
531
325
239
239325531138628611592552,6642,651201,0403,2403,8714,4644,73828
       Property Plant Equipment 
3
1,078
804
520
254
140
0
2
4
17
55
92
115
86
62
138
531
325
239
23932553113862861159255174201402545208041,0783
       Goodwill 
0
1,841
1,841
1,841
1,841
900
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000009001,8411,8411,8411,8410
       Intangible Assets 
0
1,818
1,818
1,510
1,144
900
0
0
2,648
2,648
0
0
0
0
0
0
0
0
0
0000000002,6482,648009001,1441,5101,8181,8180
       Other Assets 
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0000000003000000000
> Total Liabilities 
47
2,727
2,322
2,080
946
381
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,454
1,907
1,594
1,5941,9072,4542,1599931,7281,6701,086446121193411173819462,0802,3222,72747
   > Total Current Liabilities 
47
1,367
1,391
1,495
471
347
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,133
1,768
1,569
1,5691,7682,1332,1599931,7281,6701,086446121193411173474711,4951,3911,36747
       Short-term Debt 
0
214
180
149
0
0
141
80
57
4,350
3,598
3,259
0
0
110
110
163
165
146
146165163110110003,2593,5984,3505780141001491802140
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
0
0
0
00027000000000000000
       Accounts payable 
0
512
645
744
175
83
105
7
54
36
171
217
901
857
364
1,356
1,227
931
960
9609311,2271,35636485790121717136547105831757446455120
       Other Current Liabilities 
6
590
531
575
218
187
12
34
139
84
275
870
769
871
629
693
743
671
463
4636717436936298717698702758413934121872185755315906
   > Long-term Liabilities 
0
1,361
931
585
475
34
0
0
0
0
0
0
0
0
364
321
321
139
25
2513932132136400000000344755859311,3610
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
321
139
25
251393210000000000000000
       Other Liabilities 
0
412
188
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
00000000030000001884120
> Total Stockholder Equity
900
5,457
4,680
4,087
4,282
2,578
2,913
2,483
6,051
12,160
6,961
14,811
10,135
18,155
10,675
21,901
11,696
11,163
9,880
9,88011,16311,69621,90110,67518,15510,13514,8116,96112,1606,0512,4832,9132,5784,2824,0874,6805,457900
   Common Stock
926
5,567
6,366
8,508
8,508
8,695
9,708
9,709
13,889
23,786
23,806
35,695
36,645
52,257
52,257
70,137
70,397
79,910
86,507
86,50779,91070,39770,13752,25752,25736,64535,69523,80623,78613,8899,7099,7088,6958,5088,5086,3665,567926
   Retained Earnings -84,368-73,025-62,298-51,864-47,602-39,036-30,496-23,480-18,712-13,183-8,960-8,081-7,650-6,192-4,480-4,596-1,829-155-26
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
1,558
1,867
2,596
3,986
4,933
6,020
-18,273
-8,099
-6,885
0
0-6,885-8,099-18,2736,0204,9333,9862,5961,8671,558000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.